NASDAQ · Shell Companies
MedTech Acquisition Corporation (MTACW) Stock
$0.22
+10.00%
NASDAQ: MTACW
Financial Services
MTACW is a publicly listed Shell Companies company in the Financial Services sector, traded on US stock exchanges.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Grieving Messi available for Miami in Leagues Cup clash
AFP · Aug 12, 2026
Rio Tinto Aluminum Smelter Receives $1.8 Billion Government Bailout
MT Newswires · Aug 12, 2026
Dow Jones Futures: Cisco, Coherent Are Earnings Movers Late After Nebius, Lumentum, CoreWeave Lead AI Rally
Investor's Business Daily · Aug 12, 2026
FMS CAPITAL TRUST FULLY ALLOCATES OVER $110 MILLION IN FIRST YEAR WITH ACQUISITION OF FOUR HAMILTON SELF-STORAGE PROPERTIES
CNW Group · Aug 12, 2026
MFS Founder Paresh Raja Launches Legal Claim to Block Bankruptcy Pursuit
MT Newswires · Aug 12, 2026
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About MedTech Acquisition Corporation
MTACW is a publicly listed Shell Companies company in the Financial Services sector, traded on US stock exchanges.
the stock is valued at a price-to-earnings (P/E) ratio of -0.12, price-to-book of 1.83, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.01 and $0.25, and currently trades 12.0% below its 52-week high.
On profitability, MedTech Acquisition Corporation generates a return on equity (ROE) of 114.71% — well above the market average, a sign of a high-quality business, return on capital employed of -59.50%, an operating margin of -60.00%, a net profit margin of -86.67%.